Showing 541-550 of 21412 results for "".
- TRIC-I-HF: Tricuspid Repair Cut HF Events in Severe TRhttps://reachmd.com/news/tric-i-hf-tricuspid-repair-cut-hf-events-in-severe-tr/2488500/Key Takeaways Patients with symptomatic severe tricuspid regurgitation and increased risk of future heart-failure events had better outcomes with transcatheter tricuspid-valve repair plus medical therapy than with medical therapy alone on the 1-year hierarchical primary endpo
- Abbott and the American Diabetes Association Collaborate to Drive a Better Understanding of the Role of Nutrition Formulas to Support People with Diabetes and Obesityhttps://reachmd.com/news/abbott-and-the-american-diabetes-association-collaborate-to-drive-a-better-understanding-of-the-role-of-nutrition-formulas-to-support-people-with-diabetes-and-obesity/2467904/Individuals with diabetes and obesity may have nutritional deficiencies that go undiagnosed and untreated, which can impact overall health Providing health care professionals with nutrition tools is key to suppor
- Scientists Discover a Cause of Lupus and a Possible Way to Reverse Ithttps://reachmd.com/news/scientists-discover-a-cause-of-lupus-and-a-possible-way-to-reverse-it/2467305/Two cellular defects appear to drive disease in lupus VIDEO Jaehyuk Choi, MD, PhD, the Jack W. Graffin Professor, an associate professor of Dermatology and a Northwestern Medicine dermatologist. <
- Navigating the Interplay between Genetics, Metformin, and Mental Healthhttps://reachmd.com/news/navigating-the-interplay-between-genetics-metformin-and-mental-health/2483212/Metformin, primarily known for managing diabetes, has drawn interest for its potential association with lower depression risk in type 2 diabetes and its role in mitigating antipsychotic-associated weight gain. Research in an observational cohort suggests that
- DIREM Trial: Time-Restricted Feeding And Diabetes Remissionhttps://reachmd.com/news/direm-trial-diabetes-remission/2487337/Key Takeaways Diabetes remission was observed more often in both active lifestyle arms than with usual care. No significant difference was reported between intermittent fasting plus calorie-carbohydrate restriction and calorie-carbohydrate restriction
- Pharmacist-Led Cardiorenal Risk Optimization in a Diabetes Clinichttps://reachmd.com/news/pharmacist-led-cardiorenal-risk-optimization-in-a-diabetes-clinic/2486656/Key Takeaways A retrospective review in a community diabetes clinic found that specialist pharmacist involvement was associated with significant improvements in modifiable cardiorenal risk factors. Over a median follow-up of 6 months in 246 patients wi
- Advancements in Diabetes Management: Exploring New Pharmacological Strategieshttps://reachmd.com/news/advancements-in-diabetes-management-exploring-new-pharmacological-strategies/2483459/The field of diabetes management is undergoing continuous transformations, offering fresh opportunities for improving patient outcomes across varied demographics. The same incretin (GLP-1 and GIP) pathways that tirzepatide modulates are central to weight regulation a
- Navigating Gender-Specific Cardiovascular Risks in Diabeteshttps://reachmd.com/news/navigating-gender-specific-cardiovascular-risks-in-diabetes/2483094/The interplay between sex and diabetes significantly shapes cardiovascular risk profiles, demanding immediate attention in clinical practice. Clinicians face the challenge of tailoring assessments and interventions to manage these diverse risk patterns effectively, and current major guideli
- Early Statin Therapy: Reducing Cardiovascular Risk in Diabeteshttps://reachmd.com/news/early-statin-therapy-reducing-cardiovascular-risk-in-diabetes/2474865/Recent research confirms that early initiation of statin therapy in diabetes patients notably reduces cardiovascular events. This finding informs clinicians about the importance of integrating early statin intervention into treatment gu
- Repurposing Diabetes Medications for Prostate Cancer Treatmenthttps://reachmd.com/news/repurposing-diabetes-medications-for-prostate-cancer-treatment/2474556/Recent research has unveiled a compelling link between diabetes medications and prostate cancer management, highlighting the potential of drugs targeting peroxisome proliferator-activated receptor gamma (PPARγ) to inhibit tumor growth. For oncologists and endocri